Inventor · disambiguated record
Antonio Ponzetto
Also filed as: PONZETTO ANTONIO
0 granted patents·8 pending applications·0 citations·filing 2006–2008
Top patents by PatentIndex Score
8 records- 0137US2011045519A1Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereofGENNERO LUISA·Filed 2007·Application pending·0 cites
- 0233US2009181007A1Culture medium and pharmaceutical composition for regenerating cartilage tissue, a method, uses and products related theretoGENNERO LUISA·Filed 2007·Application pending·0 cites
- 0333US2010310544A1Composition comprising calcium ions and at least one proteolytic enzyme for use in the in vitro and in vivo regeneration of cutaneous and connective tissuesMEDEVICE S P A·Filed 2008·Application pending·0 cites
- 0432US2011206732A1Albumin for treating cancer and a pharmaceutical composition comprising the combination of an anti-neoplastic agent and albuminPESCARMONA GIAMPIERO·Filed 2008·Application pending·0 cites
- 0531US2008311625A1Immortal Pluripotent Stem Cell Line, Cell Lines Derived Therefrom, Methods of Preparing Thereof and Their UsesGENNERO LUISA·Filed 2006·Application pending·0 cites
- 0630US2010092454A1novel use of antidepressant compounds and related compositionsDE VIVO ENRICO·Filed 2007·Application pending·0 cites
- 0730US2008317730A1Compositions Useful for Recovering Original Trophism and Pigmentation, and for Stimulating Growth of the Integumentary Apparatus, Uses and Products ThereofGENNERO LUISA·Filed 2006·Application pending·0 cites
- 0824US2010130544A1Use of parasympatholytic substances to enhance and accelerate stem cell differentiation, related methods and compositionsUNIV DEGLI STUDI TORINO·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antonio Ponzetto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →